CN107847520A - 治疗炎性病症和免疫疾病的方法和组合物 - Google Patents

治疗炎性病症和免疫疾病的方法和组合物 Download PDF

Info

Publication number
CN107847520A
CN107847520A CN201680030744.5A CN201680030744A CN107847520A CN 107847520 A CN107847520 A CN 107847520A CN 201680030744 A CN201680030744 A CN 201680030744A CN 107847520 A CN107847520 A CN 107847520A
Authority
CN
China
Prior art keywords
cancer
hypochlorous acid
disease
skin
acid composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201680030744.5A
Other languages
English (en)
Chinese (zh)
Inventor
M.桑普森
S.帕尼切瓦
C.肖克默尔
E.所罗门
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Gabriel's Treatment Of Ltd By Share Ltd
Original Assignee
Gabriel's Treatment Of Ltd By Share Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US14/670,641 external-priority patent/US9999635B2/en
Application filed by Gabriel's Treatment Of Ltd By Share Ltd filed Critical Gabriel's Treatment Of Ltd By Share Ltd
Publication of CN107847520A publication Critical patent/CN107847520A/zh
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/20—Elemental chlorine; Inorganic compounds releasing chlorine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Inorganic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Rheumatology (AREA)
  • Dermatology (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
CN201680030744.5A 2015-03-27 2016-03-28 治疗炎性病症和免疫疾病的方法和组合物 Pending CN107847520A (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US14/670,641 2015-03-27
US14/670,641 US9999635B2 (en) 2007-01-16 2015-03-27 Methods and compositions for treating inflammatory disorders
PCT/US2016/024453 WO2016160668A1 (en) 2015-03-27 2016-03-28 Methods and compositions for treating inflammatory and immunological disorders

Publications (1)

Publication Number Publication Date
CN107847520A true CN107847520A (zh) 2018-03-27

Family

ID=57006380

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201680030744.5A Pending CN107847520A (zh) 2015-03-27 2016-03-28 治疗炎性病症和免疫疾病的方法和组合物

Country Status (12)

Country Link
US (2) US10617716B2 (https=)
EP (1) EP3273973A4 (https=)
JP (1) JP2018509460A (https=)
KR (1) KR20180012745A (https=)
CN (1) CN107847520A (https=)
AU (1) AU2016243554A1 (https=)
CA (1) CA2980966A1 (https=)
HK (1) HK1250337A1 (https=)
IL (1) IL254671A0 (https=)
MX (1) MX2017012433A (https=)
SG (1) SG11201707892YA (https=)
WO (1) WO2016160668A1 (https=)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112703005A (zh) * 2018-07-17 2021-04-23 费灵有限公司 包括微生物群恢复治疗（mrt）组合物的联合疗法
CN115666593A (zh) * 2020-05-21 2023-01-31 国立大学法人大阪大学 上皮癌治疗药
WO2024183061A1 (zh) * 2023-03-09 2024-09-12 英属维京群岛商白因子国际股份有限公司台湾分公司 一种次氯酸组合物用于制备预防、改善或治疗放射性皮肤炎的医药组合物的用途

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9381214B2 (en) 2011-03-18 2016-07-05 Puricore, Inc. Methods for treating skin irritation
EP3233091A4 (en) 2014-12-16 2018-07-18 Realm Therapeutics, Inc. Hypochlorous acid formulations and methods for treating skin conditions
US10617716B2 (en) 2014-12-16 2020-04-14 Urgo Us, Inc. Hypochlorous acid formulations and methods for treating skin conditions
US11324734B2 (en) 2015-04-01 2022-05-10 Akebia Therapeutics, Inc. Compositions and methods for treating anemia
ZA201707084B (en) * 2016-10-21 2018-11-28 Ultrapure Hocl Pty Ltd Hypochlorous acid
WO2018230743A1 (ja) * 2017-06-17 2018-12-20 株式会社エースネット ラジカル発生触媒、ラジカルの製造方法、酸化反応生成物の製造方法、薬剤および農畜産用薬剤
KR20210005936A (ko) * 2018-05-02 2021-01-15 오큐소프트, 인코포레이티드 차아염소산 기반 눈꺼풀 세정제
EP3993811B1 (en) * 2019-07-03 2025-02-26 Apr Applied Pharma Research S.A. Therapeutic uses of oxidising hypotonic acid solutions
JP2021171322A (ja) * 2020-04-24 2021-11-01 ニプロ株式会社 次亜塩素酸の呼吸器への導入システム
US20220079981A1 (en) * 2020-09-15 2022-03-17 Facerestoration Ltd Lavage techniques and virucidal compositions comprising hypochlorous solutions
US20220202853A1 (en) * 2020-12-28 2022-06-30 Briotech, Inc. Hypohalous acids for treating inflammatory diseases and inhibiting growth of malignancies
GB202110146D0 (en) * 2021-07-14 2021-08-25 Hypo Stream Ltd Treatment of respiratory conditions

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20100285151A1 (en) * 2007-01-16 2010-11-11 Puricore, Inc. Methods and compositions for treating conditions associated with infection and/or inflammation
CN103796515A (zh) * 2011-03-18 2014-05-14 普里科尔股份有限公司 稳定的次卤酸溶液

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH10236961A (ja) * 1997-02-25 1998-09-08 Nobel Igaku Kenkyusho:Kk 電解酸性水を用いた眼科用剤
JP2000063279A (ja) * 1998-08-07 2000-02-29 Medical Discoveries Inc 新規免疫機能向上剤
GB2355190B (en) 1999-08-23 2004-07-28 Sterilox Medical Improvements in or relating to sterilising preparations
US6333054B1 (en) 1999-10-21 2001-12-25 Amuchina S.P.A. Topical, non-cytotoxic, antimicrobial hydrogel with thixotropic properties
US20030185704A1 (en) * 2000-01-12 2003-10-02 Suzanne Bernard Physiologically balanced, ionized, acidic solution and methodology for use in wound healing
US9168318B2 (en) * 2003-12-30 2015-10-27 Oculus Innovative Sciences, Inc. Oxidative reductive potential water solution and methods of using the same
CA2602522C (en) * 2005-03-23 2014-09-09 Oculus Innovative Sciences, Inc. Method of treating skin ulcers using oxidative reductive potential water solution
EP1959972A4 (en) * 2005-12-13 2009-06-03 Puricore Inc PROCESS FOR TREATING OPEN INJURIES BY HYPOCHLOROUS ACID
EP1993571B1 (en) * 2006-01-20 2018-07-25 Sonoma Pharmaceuticals, Inc. Methods of treating or preventing inflammation and hypersensitivity with oxidative reductive potential water solution
CN101405013A (zh) 2006-01-20 2009-04-08 奥古露丝创新科学公司 使用氧化还原电位水溶液治疗或预防腹膜炎的方法
CA2650973A1 (en) 2006-05-03 2007-11-08 University Of Manitoba Microbial markers of inflammatory bowel disease
JP4372121B2 (ja) * 2006-06-24 2009-11-25 有限会社上川製作所 家畜腸内の大腸菌減少剤、家畜体内の脂肪減少剤及び家畜の飼育方法
US9999635B2 (en) 2007-01-16 2018-06-19 Realm Therapeutics, Inc. Methods and compositions for treating inflammatory disorders
US20100266710A1 (en) * 2007-07-26 2010-10-21 Mihran Baronian Pharmaceutical preparations comprising electrochemically activated hypochlorite solutions
KR101715631B1 (ko) 2008-04-01 2017-03-13 안티포딘 파마슈티칼스, 인코포레이티드 피부 관리를 위한 조성물 및 방법
JP2011116730A (ja) * 2009-12-04 2011-06-16 Yasuharu Shima 呼吸器系疾患の予防と治療方法
US20120251831A1 (en) * 2009-12-16 2012-10-04 Japan Carlit Co., Ltd Near-infrared absorptive coloring matter and near-infrared absorptive composition
US9381214B2 (en) 2011-03-18 2016-07-05 Puricore, Inc. Methods for treating skin irritation
US10617716B2 (en) 2014-12-16 2020-04-14 Urgo Us, Inc. Hypochlorous acid formulations and methods for treating skin conditions

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20100285151A1 (en) * 2007-01-16 2010-11-11 Puricore, Inc. Methods and compositions for treating conditions associated with infection and/or inflammation
CN103796515A (zh) * 2011-03-18 2014-05-14 普里科尔股份有限公司 稳定的次卤酸溶液

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112703005A (zh) * 2018-07-17 2021-04-23 费灵有限公司 包括微生物群恢复治疗（mrt）组合物的联合疗法
CN115666593A (zh) * 2020-05-21 2023-01-31 国立大学法人大阪大学 上皮癌治疗药
CN115666593B (zh) * 2020-05-21 2025-11-25 国立大学法人大阪大学 上皮癌治疗药
WO2024183061A1 (zh) * 2023-03-09 2024-09-12 英属维京群岛商白因子国际股份有限公司台湾分公司 一种次氯酸组合物用于制备预防、改善或治疗放射性皮肤炎的医药组合物的用途

Also Published As

Publication number Publication date
US20180078578A1 (en) 2018-03-22
EP3273973A1 (en) 2018-01-31
US20170360832A1 (en) 2017-12-21
WO2016160668A1 (en) 2016-10-06
AU2016243554A1 (en) 2017-10-19
CA2980966A1 (en) 2016-10-06
SG11201707892YA (en) 2017-10-30
MX2017012433A (es) 2018-03-26
EP3273973A4 (en) 2018-12-05
US10617716B2 (en) 2020-04-14
IL254671A0 (en) 2017-11-30
KR20180012745A (ko) 2018-02-06
JP2018509460A (ja) 2018-04-05
HK1250337A1 (zh) 2018-12-14

Similar Documents

Publication Publication Date Title
CN107847520A (zh) 治疗炎性病症和免疫疾病的方法和组合物
US10987379B2 (en) Hypochlorous acid formulations and methods for treating skin conditions
US10632147B2 (en) Methods and compositions for treating inflammatory disorders
US11938166B2 (en) Methods and compositions for treating mucosal tissue disorders
CN102811610B (zh) 无刺激性眼科聚维酮碘组合物
JP6753860B2 (ja) リルゾールの舌下製剤
RU2633481C2 (ru) Лечение воспалительных повреждений при розацеа с помощью ивермектина
JP2011515494A5 (https=)
JP2020097624A (ja) モメタゾンおよびオロパタジンの組み合わせを使用するアレルギー性鼻炎の治療
JP2017535612A (ja) リルゾールの舌下投与
JP2021107464A (ja) 眼科組成物
JP2018535249A (ja) ランピルナーゼおよび／またはアンフィナーゼを使用するウイルス性結膜炎の処置
WO2017019614A1 (en) Combinations and methods for the treatment and/or prevention of fungal infections
La Mantia et al. Efficacy, Safety, and Tolerability of Nasal Wash in Patients with Upper Respiratory Tract Diseases
RU2657512C1 (ru) Средство для лечения гнойного риносинусита
Maggs Managing chronic ocular conditions in dogs and cats.
Docrat The management of atopic eczema-new strategies: skin sense

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
WD01 Invention patent application deemed withdrawn after publication
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20180327